Building on the Momentum to Develop Alzheimer’s Treatments and Vaccine with Dr. Hideki Garren Prothena TRANSCRIPT
Download PDFAug 31, 2021
Hideki Garren MD Ph.D. is the Chief Medical Officer at Prothena with a mission to advance the pipeline of candidates for neurodegenerative and protein amyloid diseases, including Alzheimer's and Parkinson's. We talk about the recent FDA approval of aducanumab and its impact on research.
Hideki says, "As we've shown at...
Aug 31, 2021
Hideki Garren MD Ph.D. is the Chief Medical Officer at Prothena with a mission to advance the pipeline of candidates for neurodegenerative and protein amyloid diseases, including Alzheimer's and Parkinson's. We talk about the recent FDA approval of aducanumab and its impact on research.
Hideki says, "As we've shown at...
Accelerating Development of Treatments for Spinal Muscular Atrophy with Karen Chen SMA Foundation TRANSCRIPT
Download PDFAug 30, 2021
Karen Chen is the Chief Executive Officer of the Spinal Muscular Atrophy Foundation. With a background in drug development having worked in pharma and biotech in neurodegenerative diseases like Alzheimer's and Parkinson's, Karen brings a deep understanding of the value of treating rare diseases that are genetically...
Aug 30, 2021
Karen Chen is the Chief Executive Officer of the Spinal Muscular Atrophy Foundation. With a background in drug development having worked in pharma and biotech in neurodegenerative diseases like Alzheimer's and Parkinson's, Karen brings a deep understanding of the value of treating rare diseases that are genetically...
Understanding Role of Fragments of tRNA Synthetases in Controlling Inflammation with Sanjay Shukla aTyr Pharma TRANSCRIPT
Download PDFAug 25, 2021
Sanjay Shukla is the President and CEO of aTyr Pharma, focusing on the extracellular functionality and signaling pathways of tRNA synthetases. The lead clinical product candidate ATYR1923 is a potential disease-modifying therapy for patients with severe inflammatory lung diseases, including interstitial lung disease...